112 filings
Page 6 of 6
8-K
25d69e89njcgod8nkw7v
3 Nov 16
CytomX Therapeutics Announces Third Quarter 2016 Financial Results and Provides Pipeline Update
12:00am
8-K
9yd31m3
3 Aug 16
CytomX Announces Second Quarter 2016 Financial Results
12:00am
8-K
d8h7zg
13 Jun 16
CytomX Therapeutics Appoints John A. Scarlett, M.D., to Board of Directors
12:00am
8-K
egyv7362f7 ujz
6 May 16
CytomX Announces First Quarter 2016 Financial Results
12:00am
8-K
6dupaj41i88j553z15zu
28 Apr 16
Departure of Directors or Certain Officers
12:00am
8-K
iis6u0rjsuttj2psf
21 Apr 16
CytomX and AbbVie Announce Strategic Collaboration for Probody Drug Conjugates
12:00am
8-K
dzrsd
7 Mar 16
CytomX Announces Year-End 2015 Financial Results
12:00am
8-K
o1bg tpstsdva4yj8tq4
22 Feb 16
Regulation FD Disclosure
12:00am
8-K
w7snywd
20 Jan 16
CytomX Announces Third Target Selection by Bristol-Myers Squibb, Triggering Milestone
12:00am
8-K
3b3wjg0z
16 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
awh5lb5
23 Nov 15
CytomX Reports Third Quarter 2015 Financial Results
12:00am
8-K
9asudj m5
19 Oct 15
Amendments to Articles of Incorporation or Bylaws
12:00am